Overview
Announcements

Ordinary Adjustment | Solactive Genomics Index | Effective Date 13th May 2024

Solactive Genomics Index:

In the ordinary adjustment, the following composition will be implemented effective open 13th May 2024:

VERTEX PHARMACEUTICALS INC
GILEAD SCIENCES INC
AGILENT TECHNOLOGIES INC
MODERNA INC
BIONTECH SE
ILLUMINA INC
ALNYLAM PHARMACEUTICALS INC
BIOMARIN PHARMACEUTICAL INC
SAREPTA THERAPEUTICS INC
NATERA INC
BIO-TECHNE CORP
QIAGEN NV
CRISPR THERAPEUTICS AG
ULTRAGENYX PHARMACEUTICAL INC
ARROWHEAD PHARMACEUTICALS INC
10X GENOMICS INC
INTELLIA THERAPEUTICS INC
ROCKET PHARMACEUTICALS INC
TWIST BIOSCIENCE CORP
MYRIAD GENETICS INC
BEAM THERAPEUTICS INC
GENSCRIPT BIOTECH CORP
VERACYTE INC
REGENXBIO INC
ARCTURUS THERAPEUTICS HOLDINGS INC
EDITAS MEDICINE INC
FULGENT GENETICS INC
CAREDX INC
STOKE THERAPEUTICS INC
VERVE THERAPEUTICS INC
PACIFIC BIOSCIENCES OF CALIFORNIA INC
ALLOGENE THERAPEUTICS INC
CARIBOU BIOSCIENCES INC
TAKARA BIO INC
2SEVENTY BIO INC-W/I
UNIQURE B.V.
BLUEBIRD BIO INC
POSEIDA THERAPEUTICS INC
SANGAMO THERAPEUTICS INC
BIONANO GENOMICS INC